re: Ann: Letter to Shareholders: Acq. of Indo... Where are you getting your 2c cap raise info from if you don't mind me asking?
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling